# Sequential Chemo-immunotherapy Plus Thoracic Radiotherapy for Elderly And/or Frail Stage III Non-small-cell Lung Cancer

> **NCT05557552** · NA · RECRUITING · sponsor: **Ruijin Hospital** · enrollment: 56 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer Stage III

## Interventions

- **RADIATION:** standar thoracic RT dose
- **RADIATION:** decreased thoracic RT dose

## Key facts

- **NCT ID:** NCT05557552
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-30
- **Primary completion:** 2025-09-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2024-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05557552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05557552, "Sequential Chemo-immunotherapy Plus Thoracic Radiotherapy for Elderly And/or Frail Stage III Non-small-cell Lung Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05557552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*